News and Announcements
Why Does DMX Capital Partners Generate Positive Absolute Returns Even When the Market Falls?
- Published February 23, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
We have recently had a few questions regarding the fund’s very low correlation with the broader market, and why the fund tends to generate positive absolute returns (on average) when the market falls. By way of background, the fund’s correlation with the All Ords since launch 22 months ago is under 3%. And in the 11 of those 22 months when the market fell, DMX Capital Partners averaged a positive absolute monthly return of 2.2%, and an average monthly relative out-performance of the All Ords of 5.4%.
- In our opinion there are a few clear reasons:
1. We are investing in largely unknown and undiscovered smaller companies which are generally ignored by the broking community and broader market. By focusing on these undiscovered stocks with high upside potential and low downside risk, the fund is well placed to “do its own thing” rather than trade in line with the market. - We are disciplined value investors. By investing in companies with a significant margin of safety we are generally avoiding the stocks which tend to sell off the most during periods of market weakness; the highly valued growth stocks.
- DMX Capital Partners has a cash weighting in excess of 20% which both provides protection during periods of market weakness, and also allows us to remain on the front foot if opportunities emerge in our shortlist of high conviction stocks.
- DMX Capital Partners comprises only our 15 highest conviction stocks. We believe this is a key strength since in our experience many fund managers build larger portfolios which contain lower conviction stocks and thus create the risk of a “tail” of under-performers which often limits out-performance potential.
To view the latest DMX Capital Partners presentation please download the document below.
We are currently open to inflows into DMX Capital Partners. For those who would like to invest or top up (both within and outside of super) please register your interest by clicking on the button below.
Company Updates
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
Backed By Leading Investment Groups and Family Offices
